Is Hims The Next Big Name In Peptides? Shares Topple Despite Sales Beat.

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 4 hours ago

Billionaires like Ken Griffin are doling out tons of money to prove that a college degree still matters

Despite questions swirling around colleges and universities, Griffin’s $3 billion donation to Carnegie Mellon University is one of many from billionaires to colleges this year

MarketWatch

marketsabout 4 hours ago

Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects

The pharma giant is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes.

MarketWatch

marketsabout 4 hours ago

After I sold TOMS Shoes for $400 million I was misdiagnosed with bipolar disorder — and it almost cost me everything

Most people land in a psychiatrist’s office because something happened: a loss, a breakup, the end of a career.

MarketWatch